Cardiff Oncology is entering a pivotal stage with a strong cash runway and compelling early data in first-line RAS-mutant ...

A lunch at the Saudi royal court in Riyadh gave President Donald Trump, Saudi leaders and numerous business executives an ...

President Trump landed in Saudi Arabia on Tuesday to a very warm welcome, and he brought with him an entire entourage. As the ...

A handful of generic and biosimilar manufacturers have said they feel prepared to ride out President Donald Trump’s potential ...

Galapagos is turning heads by reconsidering whether to do its planned spinoff, which was originally announced in January.

We recently published a list of Why These 10 Stocks Soared by Double Digits Today. In this article, we are going to take a ...

Beyond the major indices, 10 companies finished the week stronger, booking double-digit gains during the day. In this article ...

The commercial distribution of ANKTIVA commenced in May 2024, and the company believes it has the potential to become a ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $129.6 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 15 ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following ...

ImmunityBio, Inc.’s IBRX share price has surged by 10.14%, which has investors questioning if this is right time to sell.

We recently published a list of 10 Low Risk High Reward Stocks Set to Triple by 2030. In this article, we are going to take a ...